Chairman David 4
4 · Valens Semiconductor Ltd. · Filed Jun 16, 2026
Research Summary
AI-generated summary of this filing
Valens (VLN) SVP David Exercises Options, Sells 4,000 Shares
What Happened
David, SVP, R&D at Valens Semiconductor Ltd., exercised stock options and sold shares on June 15, 2026. The filing shows two option exercises (4,000 shares @ $0.86 for $3,440; and 4,000 shares reported at $0.00) and an open‑market sale of 4,000 shares at a weighted average price of $2.43 for gross proceeds of $9,730. The transactions were reported on Form 4 filed the next day.
Key Details
- Transaction date: 2026-06-15 (Form 4 filed 2026-06-16 — timely).
- Exercises: 4,000 shares @ $0.86 (cost $3,440) + 4,000 shares reported at $0.00 (both listed as option exercises).
- Sale: 4,000 shares sold @ $2.43 (weighted avg) for $9,730 gross proceeds.
- Shares owned after transaction: not reported in the provided filing details.
- Notable footnotes: transactions were executed under a Rule 10b5‑1 trading plan (adopted Aug 16, 2024); the shares were acquired upon exercise of stock options and some shares sold were those newly exercised; the $2.43 is a weighted average price and full per‑lot detail is available upon request.
Context
The pattern—exercise of options and immediate sale of some shares the same day—is consistent with a cashless exercise where exercised shares are sold to cover costs/taxes. The $0.00 line likely reflects shares used to satisfy exercise price or tax withholding rather than a market sale. The filing notes the sale was made pursuant to a prearranged 10b5‑1 plan, which can explain scheduled sales and reduces the informational value of the sale as a standalone signal of insider sentiment.
Insider Transaction Report
- Exercise/Conversion
Ordinary Shares
[F2]2026-06-15$0.86/sh+4,000$3,440→ 407,968 total - Sale
Ordinary Shares
[F1][F3][F4]2026-06-15$2.43/sh−4,000$9,730→ 403,968 total - Exercise/Conversion
Stock Option (Right to Buy)
[F5]2026-06-15−4,000→ 75,695 totalExercise: $0.86From: 2022-06-01Exp: 2031-06-09→ Ordinary Shares (4,000 underlying)
Footnotes (5)
- [F1]The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024
- [F2]The shares were acquired upon the exercise of stock options
- [F3]The shares sold were acquired upon the exercise of stock options on the same date
- [F4]The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request.
- [F5]The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.